Continuous Versus Intermittent Ward Monitoring

Part of paid clinical trials in Houston, Texas.

Sponsor
The University of Texas Health Science Center, Houston
Study ID
NCT06232876
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Surgery

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Blinded continuous vital sign monitoring — DEVICE
    Continuous ward monitoring with vital signs recorded but not available to patients, clinicians, or investigators.
  • Unblinded continuous vital sign monitoring — DEVICE
    Continuous ward monitoring with vital signs available to clinicians and investigators.

Study Details

The investigators will randomize adults having major non-cardiac inpatient surgery to blinded versus unblinded continuous postoperative vital sign monitoring (saturation, ventilation, and heart rate). The investigators will use a wearable, untethered, and battery-powered sensor (Masimo Radius PPG, Masimo, Irvine, CA) that wirelessly connects to a Masimo monitor and continuously records saturation, ventilation, and pulse rate. The primary outcome will be areas-exceeding-thresholds for desaturation (\<85%), bradypnea (\<7 breaths/min), tachypnea (\>30 breaths/min), tachycardia (heart rate \>130 beats/min), and bradycardia (heart rate \<45 beats/min). These exposure thresholds represent a balance between events that are clinically meaningful and excessive alarms that will discourage clinician participation. The investigators expect about 1 alert per patient per day with these thresholds, with most being considered informative or actionable by nurses. In unblinded patients, clinician alerts will be activated at these thresholds.

Key Dates

Start date
Jun 1, 2026
Status verified
May 2026
Primary completion
Jul 1, 2028
Completion
Mar 1, 2029

Study Design

Enrollment
492 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Sham Comparator: Blinded continuous vital sign monitoring
    Continuous ward monitoring with vital signs recorded but not available to patients, clinicians, or investigators.
  • Experimental: Unblinded continuous vital sign monitoring
    Continuous ward monitoring with vital signs available to clinicians and investigators.

Primary Outcome Measure

Vital sign abnormalities with routine hospital monitors [ Time Frame: 48 postoperative hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Texas Health Science Center at HoustonHoustonTexas77030
Valerie L Anderson, BS
[email protected]
(713) 500-4383
Daniel I Sessler, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
The University of Texas Health Science Center at Houston· Houston, TX

Related Studies